A Machine Learning and Network Framework to Discover New Indications for Small Molecules

    August 2020 in “ PLOS Computational Biology ”
    Coryandar Gilvary, Jamal Elkhader, Neel S. Madhukar … Olivier Elemento
    Studysummary This study presents a computational approach, CATNIP, which repurposes drugs using only their biological and chemical information, predicting new uses like adrenergic uptake inhibitors for Parkinson's and vandetanib for Type 2 Diabetes.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.plos.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Repurposing of Approved Cardiovascular Drugs Journal of Translational Medicine · 2016